Compare OGN & WLTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OGN | WLTH |
|---|---|---|
| Founded | 1923 | 2008 |
| Country | United States | United States |
| Employees | N/A | 391 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2020 | N/A |
| Metric | OGN | WLTH |
|---|---|---|
| Price | $13.51 | $9.37 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 8 |
| Target Price | $11.40 | ★ $12.86 |
| AVG Volume (30 Days) | ★ 2.4M | 1.8M |
| Earning Date | 05-07-2026 | 05-18-2026 |
| Dividend Yield | ★ 0.60% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $6,216,000,000.00 | N/A |
| Revenue This Year | $0.45 | $10.58 |
| Revenue Next Year | $1.67 | $23.43 |
| P/E Ratio | $24.59 | ★ $10.57 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.69 | $7.20 |
| 52 Week High | $13.60 | $14.12 |
| Indicator | OGN | WLTH |
|---|---|---|
| Relative Strength Index (RSI) | 62.13 | 50.00 |
| Support Level | $13.46 | $8.57 |
| Resistance Level | $13.60 | $11.28 |
| Average True Range (ATR) | 0.05 | 0.42 |
| MACD | -0.03 | 0.11 |
| Stochastic Oscillator | 35.71 | 68.58 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Wealthfront Corp is a product-driven technology company that built a financial solutions platform for digital natives. The platform is designed to address the needs of the wealth builders within these generations. Its business model is designed to optimize for clients' success. The focus on delivering fully automated services results in being one of the lowest cost producers in each category in which participate. The group generates revenue from cash management and investment advisory products. Cash management revenue is earned from fees received for the delivery of cash management services, including the cash sweep program.